Boehringer Ingelheim
Marquis® Paste (Rx) - 4 ct box
$1,289.09
First FDA-approved treatment for equine protozoal myeloencephalitis (EPM). is indicated as an aid in reducing the clinical severity of Equine Protozoal Myeloencephalitis (EPM) caused by Sarcocystis neurona in horses; it is expected that approximately two horses out of three will respond favourably to treatment. One 127 g syringe ONLY.
This product is not eligible for any discounts.
Boehringer Ingelheim
Boehringer Ingelheim
Boehringer Ingelheim
Merck Animal Health
Merial
Zoetis®
Zoetis®
Vetoquinol USA
Zoetis®